Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: The RES trial

Journal of Hypertension

Volumn 17, Issue 12 SUPPL., 1999, Pages 1955-1963

  De Simone, Giovanni ^a   Muiesan, M Lorenza ^b   Ganau, Antonello ^c   Longhini, Carlo ^d   Verdecchia, Paolo ^e   Palmieri, Vittorio ^a   Agabiti Rosei, Enrico ^b   Mancia, Giuseppe ^f  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b University Hospital   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e Ospedale Silvestrini   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Arterial hypertension; Cardiac hypertrophy; Cardiovascular risk; Variability

Indexed keywords

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RELIABILITY; RISK ASSESSMENT;

EID: 0033506642     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917121-00027     Document Type: Conference Paper

References (29)

1. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
2. Levy D, Garrison RT, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 332:1561-1566.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
4. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117:831-836.
5. Mensah GA, Koren MJ, Ulin R, Pappas TW, Nocholson J, Laragh JH, et al. Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complication in essential hypertension. J Hypertens 1993; 11:1429-1440.
6. Verdecchia P, Porcellati C, Schillaci G, Borgini C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in arterial hypertension. Hypertension 1994; 24:793-801.
7. Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, et al. Left ventricular mass and the risk of stroke in an elderly cohort: the Framingham Heart Study. JAMA 1994; 272:33-36.
8. Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali JK. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995; 273:1592-1597.
9. ACC/AHA. Guidelines for the clinical application of echocardiography. J Am Coll Cardiol 1990; 16:1505-1528.
10. The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
11. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993; 153:154-183.
12. Devereux RB, Agabiti-Rosei E, Dahlof B, Gosse P, Hahn RT, Okin PM, et al. Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens 1996; 14 (suppl):S95-S101.
13. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 10:1091-1095.
14. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97:548-554.
15. de Simone G, Ganau A, Verdecchia P, Devereux RB. Echocardiography in arterial hypertension: when, why and how? J Hypertens 1994; 12:1129-1136.
16. Gottdiener JS, Livengood SV, Meyer PA, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol 1995; 25:424-430.
17. Wallerson DC, Devereux RB. Reproducibility of echocardiographic left ventricular measurements. Hypertension 1987; 9 (suppl II):II-6-II-8.
18. Himelman RB, Cassidy MM, Landzberg JS, Schiller NB. Reproducibility of quantitative two-dimensional echocardiography. Am Heart J 1988; 115:425-431.
19. Collins HW, Kronenberg MW, Byrd B III. Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography. J Am Coll Cardiol 1989; 14:672-676.
20. Phillips RA. Echocardiography is important to determine end-organ changes and guide management in hypertension. The Pro debate position [abstract]. Am J Hypertens 1998; 11:256A.
21. National Institute of Health Consensus Development Panel on the Health Implication of Obesity. Health implication of obesity. Ann Intern Med 1985; 103:1073-1077.
22. Sheps SG, Frohlich ED. Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension 1997; 29:560-563.
23. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
24. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
25. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 1976; 104:493-498.
26. de Simone G, Devereux RB, Daniels SR, Meyer RA. Gender differences in cardiac growth. Hypertension 1995; 26:979-983.
27. Fleiss JL. The design and analysis of clinical experiments. New York: Wiley; 1986. pp. 5-12.
28. Bland MJ, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
29. Landis JR, Koch GC. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.